The company, which currently generates around ₹700 crore in annual revenues, has been growing at about 35% a year, says Vedam ...

Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, ...

Testing thousands of genes in living tumors revealed hidden drivers of aggressive basal-like breast cancer that cell cultures ...

Discover how Dr. Ohmini Krishnamurthy Rajendran, an Indian physician-scientist, is revolutionizing precision oncology. Her ...

By identifying the genes and molecules crucial to resistance in American chestnuts and other species, researchers hope to use ...

As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier ...

Antimicrobial resistance (AMR) in mycobacterial infections has emerged as one of the most pressing challenges to global ...

By DR. ANIL KUMAR N, Senior Consultant - Medical Oncology, Hemato Oncology & BMT, Cytecare Hospitals, Bangalore , Bizz Impact ...

Microbiome sequencing has a reputation issue. From the outside, it appears to be one of modern biology's most powerful tools: ...

Eliminating unnecessary PCR cleanup and normalization steps helps genomics laboratories reduce consumable waste and ...

Bioinformatics has rapidly evolved from a niche discipline into a global economic and scientific powerhouse. As DNA ...

Tempus AI has agreed to acquire the cancer genomics company Personalis in a deal valued at about $1.5 billion, the companies announced July 20. The acquisition builds on a partnership the two ...